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Volume 59, Number 6S Abstracts 73SObjectives: Endovascular intervention (EVI) is in-
creasingly performed in patients with tissue loss (TL) and
complex anatomy who would otherwise require primary
amputation (PA). Guidelines for intervention/outcome
analysis have been limited. We compared outcomes and
costs associated with secondary amputation (SA) for non-
healing TL after EVI with PA in patients with critical
limb ischemia (CLI) and TL.
Methods: All patients who presented to our health
care system for surgical management of TL due to CLI
from 2008 to 2010 were identiﬁed. Demographics, comor-
bidities, postoperative complications, insurer costs, follow-
up hospitalizations, ambulatory/living status were analyzed
(SPSS 21).
Results: There were 304 admissions: 263 (87%) EVI
and 41 (13%) PA. Mean follow-up was 27 months (range,
0-101 months). SA was required in 80 (30%); mean time
6 months (range, 0-46 months). Independent predictors
(likelihood ratio) for SA were contralateral amputation
(4.1), gangrene (3.6), dialysis (3.1), TL not conﬁned to
the toes or heel alone (4.3), and preoperative angiogram
showing less than two-vessel runoff (3.1). Comorbidities
were comparable for SA and PA, including location of TL
and presence of gangrene. Infection was more common in
PA (87.8% vs 57.5%; P ¼ .001). Postoperative mortality
was higher for PA (4.9% vs 0%; P ¼ .05), and 24-month sur-
vival was poorer (74% 6 8% vs 87% 6 4%; P ¼ .03). Hos-
pitalizations (including amputation-related readmission),
total hospital days, and insurer costs were higher for SA
than PA (Table). Thirty-nine (48%) SA underwent reinter-
vention. There were no signiﬁcant differences between SA
and PA in maintenance of independent living (71% vs
72%; P ¼ .95) or ambulation (42% vs 58%; P ¼ .33).
Conclusions: Although ambulation and maintenance
of independent living are comparable between SA and PA,
EVI may be justiﬁed because of higher mortality in the PA
group. However, multiple reinterventions will increase costs
and incapacitation without improving outcome.Table. Comparison of insurer costs and hospitalizations
for primary amputation versus early secondary amputation
following endovascular intervention without healing
PA SA P
Insurer costs $30,234 $68,012 <.001
Hospitalizations $4 0% 31% <.001
Total hospital days 20 35 .015
Table. Range of practice pattern for lower extremity
arterial disease among VQI regional groups
Min Max
All patients with claudication (vs all other
indications), %
24 64
Claudicants receiving bypass (vs PVI), % 6 45
Infrapopliteal PVI for claudication (vs all other
indications), %
11 27
Prosthetic graft for infrapopliteal bypass
(vs vein), %
18 45
Bypass patients with chlorhexidine prep
(post-2011), %
50 92
Infrapopliteal PVI for TASC D, % 16 74
Infrapopliteal PVI with stent (vs PTA only), % 21 58
All patients discharged on antiplatelet and
statin, %
52 77
All patients with congestive heart failure, % 10 21
All patients with dialysis dependence, % 4 16Author Disclosures: G. Cherr: Nothing to disclose; G.
R. Curl: Nothing to disclose; H. H. Dosluoglu: Nothing
to disclose; M. Dryjski: Nothing to disclose; L. Harris:
Nothing to disclose; S. Noor: Nothing to disclose; M.
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Objectives: Studies have shown regional differences in
surgical practice though management of lower extremity
arterial disease (PAD) has not been investigated. We used
the Society for Vascular Surgery Vascular Quality Initiative
(SVS VQI) to evaluate regional variation in PAD
management.
Methods: SVS VQI was used to identify all infraingui-
nal bypass or endovascular intervention (PVI) from 2009
to 2012. Each of 14 quality groups was considered a re-
gion. Groups were deidentiﬁed. Indications and surgi-
cal approach were compared between groups. Groups
with fewer than 100 cases were excluded on a per analysis
basis.
Results: We identiﬁed 29,131 patients (20,987 PVI
[48% claudicants], 8144 bypass [27% claudicants]) from
14 regions. Median case number per region was 1090
(range, 115-10,251). Substantial regional differences in pa-
tient comorbidities (eg, congestive heart failure, dialysis),
indication for procedures (eg, infrapopliteal PVI for
TASC D lesions), technical approach (eg. usage of pros-
thetic graft for infrapopliteal bypass graft) and use of evi-
dence-based process measures (eg, chlorhexidine skin
preparation for bypass) are demonstrated in the Table (P
< .001 for all listed parameters).
Conclusions: This ﬁrst investigation of a national clin-
ical database demonstrates signiﬁcant regional variation in
PAD management. Future studies on the association of
regional variation with risk-adjusted outcomes offer the op-
portunity for quality improvement through prospective
identiﬁcation of best practices.Author Disclosures: S. Berthiaume: Nothing to disclose;
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Objectives: To assess the efﬁcacy and durability of
endovascular therapy (EVT) as a ﬁrst approach, we eval-
uated the short- and long-term outcomes of the ﬁrst re-
vascularizations achieved using EVT-ﬁrst compared with
bypass surgery (BSX)-ﬁrst. Next, we explored factors
inﬂuencing overall survival (OS) using multivariate
analyses.
Methods: A total of 228 consecutive below-the-knee
(BTK) revascularization procedures (189 patients) for crit-
ical limb ischemia (CLI) between November 2006 and
September 2013 were retrospectively analyzed. Patients
undergoing revascularization were divided into two
groups. No statistically signiﬁcant differences were noted
between the two groups with respect to preoperative
background.
Results: The average age was 74.7 years (123 men
and 66 women) in both groups. The ratio of lost to
follow-up of all subjects was only 1.1%. Mean follow-up
periods were 22.6 (range, 3-86) months. No signiﬁcant
differences were noted in the short-term results in
EVT-ﬁrst revascularizations compared in BSX-ﬁrst. The
long-term OS rates were slightly better in BSX-ﬁrst
than in EVT-ﬁrst. Multivariate-analysis of all subjects
revealed that the OS rates were not affected by EVT-ﬁrst
but by ﬁve severe risk factors as follows: (1) age >80
years, (2) hemodialysis, (3) congestive heart failure,
(4) serum albumin <3 g/dL, and (5) a nonambulatory
limb.
Conclusions: OS in patients with CLI due to BTK
lesions is worse with three or more of the severe risk
factors, and in such patient the EVT-ﬁrst procedure is
effective.Table. Multivariate analysis for overall survival using of
signiﬁcant parameters according to univariate analysis.
Variables (N¼189) HR P
Age >80 years 2.6 <.01
EVT ﬁrst 1.3 .44
Hemodialysis 1.7 .03
Congestive heart failure 3.0 <.01
Nonambulatory leg 1.7 .04
Albumin <3.0 2.2 .02
Body mass index <18.5 1.3 .23
C-creative protein >3.0 1.2 .43Author Disclosures: K. Iwasa: Nothing to disclose; T.
Ohmine: Nothing to disclose; T. Yamaoka: Nothing to
disclose.PS168.
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Objectives: Optimal patient selection for revasculariza-
tion remains a clinical challenge among the hemodialy-
sis (HD) dependent, despite advances in surgical care and
endovascular techniques. The purpose of this study was to
examine contemporary real world outcomes of HD patients
to facilitate patient selection for revascularization.
Methods: A regional multicenter registry was queried
between 2003 and 2013 for HD-dependent patients (N ¼
689) undergoing open surgical bypass (n ¼ 295) or endo-
vascular intervention (n ¼ 394) for lower extremity revas-
cularization. Patient demographics and comorbidities were
recorded. The primary outcome was overall survival. Sec-
ondary outcomes included amputation-free survival
(AFS), graft patency, and freedom from major adverse
limb event (MALE). Short-term and long-term outcomes
were examined. Multivariate analysis was performed to
identify independent risk factors for MALE and death.
Results: Among the 689 HD patients undergoing
lower extremity revascularization, 66% were male and
83% white. Tissue loss was the most common indication
for intervention. The 1-, 2-, and 5-year overall survival
remained low at 59%, 43%, and 21%, respectively.
Observed 1-year and 2-year AFS was at 40% and 17%.
Mortality was the primary mode of failure for AFS, (70%
bypass, 80% endovascular; P ¼ .08). Survival and AFS
did not differ signiﬁcantly between revascularization tech-
niques. Multivariate analysis identiﬁed age >80 (HR, 1.5;
P ¼ .014), preadmission nursing home status (HR, 2.19;
P ¼ .001), chronic obstructive pulmonary disease (HR,
1.46; P ¼ .038), and preoperative wheelchair/bedridden
status (HR, 1.94; P < .001) as independent predictors of
MALE or death.
Conclusions: Overall survival and AFS among HD-
dependent patients remains poor, irrespective of revasculariza-
tion strategy. Mortality remains the primary driver for these
ﬁndings. Focus for improved results should emphasize predictors
of survival to optimize patient selection for revascularization.
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